Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management
Nutrition, Metabolism and Cardiovascular Diseases, 2010 - Elsevier
The metabolic syndrome (MetS) is characterized by the presence of central obesity,
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
Endothelial dysfunction in metabolic syndrome
K Tziomalos, A Karagiannis, V Athyros, DP Mikhailidis - 2010 - ikee.lib.auth.gr
The metabolic syndrome (MetS) is characterized by the presence of central obesity,
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management
K Tziomalos, VG Athyros… - Nutrition …, 2010 - pubmed.ncbi.nlm.nih.gov
The metabolic syndrome (MetS) is characterized by the presence of central obesity,
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.
K Tziomalos, VG Athyros, A Karagiannis… - Nutrition, Metabolism …, 2009 - europepmc.org
The metabolic syndrome (MetS) is characterized by the presence of central obesity,
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management
K Tziomalos, VG Athyros, A Karagiannis… - Nutrition, Metabolism …, 2010 - nmcd-journal.com
The metabolic syndrome (MetS) is characterized by the presence of central obesity,
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
[引用][C] Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management
K Tziomalos, VG Athyros, A Karagiannis… - Nutrition, Metabolism …, 2010 - cir.nii.ac.jp
Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management
K Tziomalos, VG Athyros, A Karagiannis… - Nutrition, Metabolism …, 2010 - infona.pl
The metabolic syndrome (MetS) is characterized by the presence of central obesity,
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
[PDF][PDF] Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management
K Tziomalos, VG Athyros, A Karagiannis… - researchgate.net
The metabolic syndrome (MetS) is characterized by the presence of central obesity,
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …
impaired glucose metabolism, dyslipidemia and hypertension. Several studies showed that …